文献速递冠心病

无复流是STEMI直接PCI后对比剂肾损伤和死亡的独立预测因素

The No‐Reflow Phenomenon as an Independent Predictor of Contrast‐Induced Acute Kidney Injury and Mortality in STEMI Patients Undergoing Primary PCI
RSS 订阅 · Catheterization and Cardiovascular Interventions · 2026-09-29

本研究为前瞻性观察性研究,纳入299例接受直接PCI的STEMI患者,评估无复流现象与对比剂急性肾损伤(CI-AKI)的关系及其对死亡率的影响。结果显示无复流是CI-AKI的独立预测因素,CI-AKI又与短期及长期死亡率升高独立相关。

要点

  • 无复流现象显著增加STEMI直接PCI后发生CI-AKI的风险
  • 发生CI-AKI的STEMI患者全因死亡率明显高于未发生者
  • 直接PCI术中应关注无复流防治以降低肾损伤和死亡风险

核心结论

  • 无复流现象是STEMI患者直接PCI后发生CI-AKI的强独立预测因素
  • CI-AKI与短期和长期死亡率升高独立相关

研究设计与样本

  • 本研究为前瞻性观察性研究
  • 共纳入299例接受直接PCI的STEMI患者

主要发现

  • CI-AKI发生率为14.04%(42例)
  • 发生CI-AKI的患者年龄更大、炎症指标(WBC、CRP)更高、左室射血分数更低
  • CI-AKI组无复流发生率为73.8%,非CI-AKI组为15.2%,p<0.001
  • CI-AKI组全因死亡率为21.4%,非CI-AKI组为7.4%,p=0.008

关键数值与推荐

  • CI-AKI定义为对比剂后48–72小时内血清肌酐升高≥25%或≥0.5 mg/dL
  • 无复流定义为最终远端血流<TIMI III和/或心肌染色缺失
  • 多因素分析中无复流预测CI-AKI的OR为10.925,95%CI为3.709–32.181,p<0.001

临床怎么用

  • 对STEMI直接PCI患者应积极预防和处理无复流现象
  • 可将无复流视为CI-AKI和不良预后的高危标志
  • 对发生无复流患者应加强肾功能监测和综合管理

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ABSTRACT Background Contrast-induced acute kidney injury (CI-AKI) frequently complicates primary percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). The no-reflow phenomenon, a primary cause of inadequate reperfusion, is linked to systemic inflammation and CI-AKI development. Aims This study evaluated the association between no-reflow and CI-AKI, and the subsequent impact on short- and long-term mortality. Methods This prospective observational study included 299 STEMI patients undergoing primary PCI. CI-AKI was defined as a serum creatinine increase ≥ 25% or ≥0.5 mg/dL within 48–72 h post-contrast. No-reflow was diagnosed if final distal flow was <TIMI III and/or myocardial blush was absent. Results CI-AKI occurred in 14.04% (42 patients). These patients were older, had higher inflammatory markers (WBC, CRP), and lower left ventricular ejection fraction. The incidence of no-reflow was significantly higher in the CI-AKI group (73.8% vs. 15.2%, p < 0.001). Multivariate analysis identified the no-reflow phenomenon as an independent predictor of CI-AKI (OR: 10.925, 95% CI: 3.709–32.181, p < 0.001). Furthermore, all-cause mortality was significantly higher in patients with CI-AKI (21.4% vs. 7.4%, p = 0.008), and CI-AKI was independently associated with poor long-term survival. Conclusion The no-reflow phenomenon is a strong, independent predictor of CI-AKI following primary PCI in STEMI patients. Additionally, CI-AKI is independently associated with increased short- and long-term mortality.

来源:Catheterization and Cardiovascular Interventions,查看原文。版权归原作者所有。

引用

  1. Catheterization and Cardiovascular Interventions:The No‐Reflow Phenomenon as an Independent Predictor of Contrast‐Induced Acute Kidney Injury and Mortality in STEMI Patients Undergoing Primary PCI

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。